S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
NASDAQ:PMVP

PMV Pharmaceuticals Insider Trades

$15.27
-0.53 (-3.35%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$14.65
$16.22
50-Day Range
$15.27
$24.92
52-Week Range
$14.65
$43.63
Volume
759,051 shs
Average Volume
734,250 shs
Market Capitalization
$692.95 million
P/E Ratio
5.76
Dividend Yield
N/A
Beta
0.95

PMV Pharmaceuticals (NASDAQ:PMVP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.80%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$30.18 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get PMVP Insider Trade Alerts

Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


PMV Pharmaceuticals (NASDAQ PMVP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/6/2021Thilo SchroederDirectorSell800$30.15$24,120.00  
10/4/2021Thilo SchroederDirectorSell100$30.08$3,008.00  
10/1/2021Thilo SchroederDirectorSell11,541$30.10$347,384.10  
9/29/2021Thilo SchroederDirectorSell5,708$30.04$171,468.32  
9/27/2021Thilo SchroederDirectorSell1,753$30.11$52,782.83  
9/22/2021Arnold J LevineDirectorSell3,500$30.00$105,000.00  
9/17/2021Thilo SchroederDirectorSell711$30.03$21,351.33  
9/13/2021Thilo SchroederDirectorSell13,272$30.20$400,814.40  
9/9/2021Thilo SchroederDirectorSell14,329$30.31$434,311.99  
9/7/2021Leila AllandInsiderSell3,900$30.25$117,975.00  
9/1/2021Thilo SchroederDirectorSell21,986$30.38$667,934.68  
8/30/2021Thilo SchroederDirectorSell13,233$30.05$397,651.65  
8/27/2021Thilo SchroederDirectorSell24,442$30.52$745,969.84  
8/25/2021Thilo SchroederDirectorSell13,526$31.01$419,441.26  
8/23/2021Arnold J. LevineDirectorSell3,500$29.50$103,250.00413,342  
8/18/2021Thilo SchroederDirectorSell26,864$33.34$895,645.76  
8/16/2021Thilo SchroederDirectorSell22,183$33.89$751,781.87  
8/13/2021Thilo SchroederDirectorSell27,286$34.24$934,272.64  
8/11/2021Thilo SchroederDirectorSell34,439$34.04$1,172,303.56  
8/9/2021Leila AllandInsiderSell4,471$34.04$152,192.84  
8/9/2021Thilo SchroederDirectorSell22,182$35.53$788,126.46  
8/6/2021Thilo SchroederDirectorSell19,900$36.61$728,539.00  
8/4/2021Thilo SchroederDirectorSell52,860$35.85$1,895,031.00  
8/3/2021Winston KungCFOSell4,500$33.82$152,190.006,100  
8/2/2021Thilo SchroederDirectorSell13,031$34.74$452,696.94  
7/28/2021Thilo SchroederDirectorSell8,724$35.76$311,970.24  
7/26/2021Thilo SchroederDirectorSell4,839$35.73$172,897.47  
7/22/2021Thilo SchroederDirectorSell200$35.61$7,122.00  
7/20/2021Arnold J LevineDirectorSell3,500$35.12$122,920.00  
7/20/2021David Henry MackCEOSell1,029$35.53$36,560.37  
7/8/2021Winston KungCFOSell4,500$33.75$151,875.00  
7/7/2021Leila AllandInsiderSell4,000$32.30$129,200.00  
6/28/2021David Henry MackCEOSell204$35.53$7,248.1212,674  
6/21/2021Arnold J LevineDirectorSell3,500$33.25$116,375.00420,453  
6/14/2021Euclidean Capital LlcMajor ShareholderSell44,419$34.11$1,515,132.09  
6/11/2021Euclidean Capital LlcMajor ShareholderSell21,977$33.80$742,822.60  
6/9/2021Euclidean Capital LlcMajor ShareholderSell39,638$33.64$1,333,422.32  
6/7/2021Euclidean Capital LlcMajor ShareholderSell30,721$33.62$1,032,840.02  
6/7/2021Leila AllandInsiderSell4,000$33.60$134,400.004,000  
6/4/2021Winston KungCFOSell4,500$33.75$151,875.006,100  
6/1/2021Richard A HeymanDirectorSell3,900$32.55$126,945.00  
5/28/2021Thilo SchroederDirectorSell5,100$35.80$182,580.00  
5/26/2021Thilo SchroederDirectorSell7,487$35.66$266,986.42  
5/24/2021Thilo SchroederDirectorSell22,095$36.03$796,082.85  
5/21/2021David Henry MackCEOSell6,207$35.71$221,651.9710,263  
5/20/2021Arnold J. LevineDirectorSell3,500$34.51$120,785.00426,803  
5/10/2021Thilo SchroederDirectorSell1,787$35.67$63,742.29  
5/7/2021Leila AllandInsiderSell4,000$34.83$139,320.004,000  
5/5/2021Thilo SchroederDirectorSell600$35.64$21,384.00  
5/3/2021Winston KungCFOSell4,500$33.75$151,875.006,100  
4/12/2021Thilo SchroederDirectorSell3,903$31.41$122,593.23  
4/8/2021Thilo SchroederDirectorSell136,436$34.31$4,681,119.16  
4/7/2021Leila AllandInsiderSell4,000$33.86$135,440.004,000  
4/5/2021Thilo SchroederDirectorSell48,193$33.81$1,629,405.33  
3/31/2021Thilo SchroederDirectorSell33,626$32.52$1,093,517.52  
3/29/2021Thilo SchroederDirectorSell2,174$32.15$69,894.10  
3/26/2021Thilo SchroederDirectorSell35,268$33.44$1,179,361.92  
3/24/2021Thilo SchroederDirectorSell34,881$36.50$1,273,156.50  
9/29/2020Ra Capital Management, L.P.Major ShareholderBuy950,000$18.00$17,100,000.00
(Data available from 1/1/2013 forward)












PMV Pharmaceuticals (NASDAQ:PMVP) Insider Trade Frequently Asked Questions

Who is on PMV Pharmaceuticals's Insider Roster?

The list of insiders at PMV Pharmaceuticals includes Arnold J Levine, David Henry Mack, Euclidean Capital Llc, Leila Alland, Ra Capital Management, L.P., Richard A Heyman, Thilo Schroeder, and Winston Kung.Learn more on PMVP's insiders

What percentage of PMV Pharmaceuticals stock is owned by insiders?

21.80% of PMV Pharmaceuticals stock is owned by insiders. Learn more on PMVP's insider holdings

Which PMV Pharmaceuticals insiders have been buying company stock?

The following insider purchased PMV Pharmaceuticals stock in the last 24 months: Ra Capital Management, L.P. ($17,100,000.00).

How much insider buying is happening at PMV Pharmaceuticals?

Insiders have purchased a total of 950,000 PMV Pharmaceuticals shares in the last 24 months for a total of $17,100,000.00 bought.

Which PMV Pharmaceuticals insiders have been selling company stock?

The following insiders have sold PMV Pharmaceuticals stock in the last 24 months: Arnold J Levine ($344,295.00), David Henry Mack ($265,460.46), Euclidean Capital Llc ($4,624,217.03), Leila Alland ($808,527.84), Richard A Heyman ($126,945.00), Thilo Schroeder ($23,176,448.66), and Winston Kung ($607,815.00).

How much insider selling is happening at PMV Pharmaceuticals?

Insiders have sold a total of 893,425 PMV Pharmaceuticals shares in the last 24 months for a total of $30,177,743.99 sold.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.